← Back to search
MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION)
JACKSONVILLE, FL, 32224
Unclaimed
Subcontracting experience
10 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | National Aeronautics and Space Administration | OBJECTIVE: TO COLLABORATE WITH BIOSERVE AND EVALUATE IN-SPACE EXPANSION OF UMBILICAL CORDDERIVED
CD34+ CELLS FOR CLINICAL APPLICATION IN THE FUTURE.
• WORK TO BE PERFORMED: THE MAYO TEAM WILL PROVIDE UMBILICAL CORD-DERIVED CD34 AND
PERFORM EXPERIMENTS TO CHARACTERIZE THE CELLS BEFORE AND AFTER EXPANSION UNDER
MICROGRAVITY CONDITIONS. OPTIMIZE CELL CULTURE IN BICEP AND PERFORM EXPERIMENT
VERIFICATION TESTS AS NEEDED.
DELIVERABLES:
• 10 – 15 VIALS OF UC-CD34+ CELLS WITH 0.5M CELLS/ VIAL
• FLOW CYTOMETRY/CELL VIABILITY AND CFU RESULTS TO CHARACTERIZE THE PRE AND POST IN-SPACE
CULTURE SAMPLES OF UC-CD34+ CELLS 1567607 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541715 Parent award performance state: CO Parent award description: IN SPACE EXPANSION OF HEMATOPOIETIC STEM CELLS FOR CLINICAL APPLICATION, PHASE 1B View parent award on USAspending | 80JSC025DA003USAspending | $184,130 | Apr 16, 2026 | — – — |
| Subcontractor | National Aeronautics and Space Administration | ABBA C ZUBAIR MD., PHD IS THE MEDICAL DIRECTOR OF TRANSFUSION MEDICINE AND STEM THERAPY LABORATORY AND PROFESSOR OF LABORATORY MEDICINE AND PATHOLOGY. DR. ZUBAIR IS THE CO-PRINCIPAL INVESTIGATOR OF THIS PROJECT. HE WILL BE RESPONSIBLE FOR MANAGING AND COORDINATING THE PORTION OF THE RESEARCH TO BE CARRIED OUT AT MAYO CLINIC FLORIDA. HE IS EXPERT IN GENERATING AND CHARACTERIZING HEMATOPOIETIC STEM CELLS (HSC) FOR BONE MARROW TRANSPLANT AND REGENERATIVE MEDICINE APPLICATION. HE HAS OVER 18 YEARS’ EXPERIENCE IN CELL THERAPY AND GROWING MSC UNDER DIFFERENT CONDITIONS. HE SUCCESSFULLY GREW AND CHARACTERIZED HSC AT ISS UNDER MICROGRAVITY CONDITION. DR. ZUBAIR WILL ENSURE THAT KNOWLEDGE GENERATED AS THE PROJECT PROCEEDS IS SHARED. HE WILL BE RESPONSIBLE TO ENSURE SUCCESS OF HIS RESEARCH TEAM EFFORT. DR. ZUBAIR WILL CONSULT AND COLLABORATE WITH DR. STODIECK’S LAB, BIOSERVE, COLORADO UNIVERSITY TO CONDUCT THE EXPERIMENTS PROPOSED IN THIS GRANT PROPOSAL. HE AND HIS TEAM WILL BE RESPONSIBLE FOR GENERATING, ANALYZING HSC TO BE USED IN THIS PROJECT, CONDUCTING ALL PREFLIGHT VALIDATION STUDIES AND WILL PERFORM FURTHER EXPERIMENTS POSTFLIGHT AND HELP IN THE DATA ANALYSIS. HIS TEAM, WITH ASSISTANCE OF DR. STODIECK’S TEAM WILL PERFORM ALL EXPERIMENTS AS OUTLINED UNDER EACH SPECIFIC AIMS AND SUB-AIMS. ZUBAIR’S TEAM WILL BE RESPONSIBLE FOR GENERATING, COLLECTING AND ANALYZING ALL BIOLOGICAL DATA. WITH INPUT FROM RELEVANT COLLABORATORS, HIS TEAM WILL PREPARE MANUSCRIPTS FOR PUBLICATION IN PEER REVIEWED JOURNALS. 1562422 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541990 Parent award performance state: CO Parent award description: PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS, LYMPHOMAS, MULTIPLE MYELOMA), FATAL BLOOD DISORDERS, AND SEVERE IMMUNE DISEASES. View parent award on USAspending | 80JSC019D0026USAspending | $68,151 | Apr 3, 2026 | — – — |
| Subcontractor | National Aeronautics and Space Administration | ZUBAIR’S TEAM, MAYO CLINIC FLORIDA: ABBA C ZUBAIR MD., PHD IS THE MEDICAL DIRECTOR OF
TRANSFUSION MEDICINE AND STEM THERAPY LABORATORY AND PROFESSOR OF LABORATORY MEDICINE AND
PATHOLOGY. DR. ZUBAIR IS THE CO-PRINCIPAL INVESTIGATOR OF THIS PROJECT. HE WILL BE RESPONSIBLE FOR
MANAGING AND COORDINATING THE PORTION OF THE RESEARCH TO BE CARRIED OUT AT MAYO CLINIC FLORIDA. HE
IS EXPERT IN GENERATING AND CHARACTERIZING HEMATOPOIETIC STEM CELLS (HSC) FOR BONE MARROW
TRANSPLANT AND REGENERATIVE MEDICINE APPLICATION. HE HAS OVER 18 YEARS’ EXPERIENCE IN CELL THERAPY
AND GROWING MSC UNDER DIFFERENT CONDITIONS. HE SUCCESSFULLY GREW AND CHARACTERIZED HSC AT ISS
UNDER MICROGRAVITY CONDITION. DR. ZUBAIR WILL ENSURE THAT KNOWLEDGE GENERATED AS THE PROJECT
PROCEEDS IS SHARED. HE WILL BE RESPONSIBLE TO ENSURE SUCCESS OF HIS RESEARCH TEAM EFFORT. DR. ZUBAIR
WILL CONSULT AND COLLABORATE WITH DR. STODIECK’S LAB, BIOSERVE, COLORADO UNIVERSITY TO CONDUCT THE
EXPERIMENTS PROPOSED IN THIS GRANT PROPOSAL. HE AND HIS TEAM WILL BE RESPONSIBLE FOR GENERATING,
ANALYZING HSC TO BE USED IN THIS PROJECT, CONDUCTING ALL PREFLIGHT VALIDATION STUDIES AND WILL PERFORM
FURTHER EXPERIMENTS POSTFLIGHT AND HELP IN THE DATA ANALYSIS. HIS TEAM, WITH ASSISTANCE OF DR.
STODIECK’S TEAM WILL PERFORM ALL EXPERIMENTS AS OUTLINED UNDER EACH SPECIFIC AIMS AND SUB-AIMS.
ZUBAIR’S TEAM WILL BE RESPONSIBLE FOR GENERATING, COLLECTING AND ANALYZING ALL BIOLOGICAL DATA. WITH
INPUT FROM RELEVANT COLLABORATORS, HIS TEAM WILL PREPARE MANUSCRIPTS FOR PUBLICATION IN PEER REVIEWED
JOURNALS. 1562422 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541990 Parent award performance state: CO Parent award description: PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS, LYMPHOMAS, MULTIPLE MYELOMA), FATAL BLOOD DISORDERS, AND SEVERE IMMUNE DISEASES. View parent award on USAspending | 80JSC019D0026USAspending | $90,000 | Jan 27, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | IN HER ROLE AS A MEMBER OF THE FRAMINGHAM HEART STUDY APRC AND BROC, DR. ERTEKIN-TANER WILL ATTEND MONTHLY MEETINGS, REVIEW PROPOSALS ASSIGNED TO HER, AND PROVIDE INPUT REGARDING OTHER PROPOSALS DISCUSSED AT THESE COMMITTEES. III. OBJECTIVES 1. ATTEND MONTHLY MEETINGS AND AD HOC MEETINGS AS APPLICABLE. 2. REVIEW ASSIGNED PROPOSALS. 3. PROVIDE CONSULTATION ON OTHER PROPOSALS. KC4079 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: FRAMINGHAM HEART STUDY (FHS), TASK AREA A - CORE STUDY OPERATIONS View parent award on USAspending | 75N92025D00012USAspending | $154,918 | Sep 5, 2025 | — – — |
| Subcontractor | National Aeronautics and Space Administration | ABBA C ZUBAIR MD., PHD IS THE MEDICAL DIRECTOR OF TRANSFUSION MEDICINE AND STEM THERAPY LABORATORY AND PROFESSOR OF LABORATORY MEDICINE AND PATHOLOGY. DR. ZUBAIR IS THE CO-PRINCIPAL INVESTIGATOR OF THIS PROJECT. HE WILL BE RESPONSIBLE FOR MANAGING AND COORDINATING THE PORTION OF THE RESEARCH TO BE CARRIED OUT AT MAYO CLINIC FLORIDA. HE IS EXPERT IN GENERATING AND CHARACTERIZING HEMATOPOIETIC STEM CELLS (HSC) FOR BONE MARROW TRANSPLANT AND REGENERATIVE MEDICINE APPLICATION. HE HAS OVER 18 YEARS’ EXPERIENCE IN CELL THERAPY AND GROWING MSC UNDER DIFFERENT CONDITIONS. HE SUCCESSFULLY GREW AND CHARACTERIZED HSC AT ISS UNDER MICROGRAVITY CONDITION. DR. ZUBAIR WILL ENSURE THAT KNOWLEDGE GENERATED AS THE PROJECT PROCEEDS IS SHARED. HE WILL BE RESPONSIBLE TO ENSURE SUCCESS OF HIS RESEARCH TEAM EFFORT. DR. ZUBAIR WILL CONSULT AND COLLABORATE WITH DR. STODIECK’S LAB, BIOSERVE, COLORADO UNIVERSITY TO CONDUCT THE EXPERIMENTS PROPOSED IN THIS GRANT PROPOSAL. HE AND HIS TEAM WILL BE RESPONSIBLE FOR GENERATING, ANALYZING HSC TO BE USED IN THIS PROJECT, CONDUCTING ALL PREFLIGHT VALIDATION STUDIES AND WILL PERFORM FURTHER EXPERIMENTS POSTFLIGHT AND HELP IN THE DATA ANALYSIS. HIS TEAM, WITH ASSISTANCE OF DR. STODIECK’S TEAM WILL PERFORM ALL EXPERIMENTS AS OUTLINED UNDER EACH SPECIFIC AIMS AND SUB-AIMS. ZUBAIR’S TEAM WILL BE RESPONSIBLE FOR GENERATING, COLLECTING AND ANALYZING ALL BIOLOGICAL DATA. WITH INPUT FROM RELEVANT COLLABORATORS, HIS TEAM WILL PREPARE MANUSCRIPTS FOR PUBLICATION IN PEER REVIEWED JOURNALS. 1562422 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541990 Parent award performance state: CO Parent award description: PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS, LYMPHOMAS, MULTIPLE MYELOMA), FATAL BLOOD DISORDERS, AND SEVERE IMMUNE DISEASES. View parent award on USAspending | 80JSC019D0026USAspending | $250,000 | May 28, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | IN HER ROLE AS A MEMBER OF THE FRAMINGHAM HEART STUDY EXECUTIVE COMMITTEE, DR. ERTEKIN-TANER WILL ATTEND TWICE MONTHLY MEETINGS, REVIEW PROPOSALS ASSIGNED TO HER, PROVIDE INPUT REGARDING OTHER PROPOSALS AND POLICY MATTERS DISCUSSED AT THE EXECUTIVE COMMITTEE LEVEL. III. OBJECTIVES 1. ATTEND TWICE MONTHLY MEETINGS AND AD HOC MEETINGS AS APPLICABLE. 2. REVIEW ASSIGNED PROPOSALS. 3. PROVIDE CONSULTATION ON OTHER PROPOSALS AND POLICY MATTERS. 4500005067 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MA Parent award description: FRAMINGHAM HEART STUDY TASK ORDER 1 - BASE PERIOD View parent award on USAspending | 75N92019D00031USAspending | $63,594 | Jun 25, 2024 | — – — |
| Subcontractor | National Aeronautics and Space Administration | ZUBAIR€„¢S TEAM, MAYO CLINIC FLORIDA: ABBA C ZUBAIR MD., PHD IS THE MEDICAL DIRECTOR OF TRANSFUSION MEDICINE AND STEM THERAPY LABORATORY AND PROFESSOR OF LABORATORY MEDICINE AND PATHOLOGY. DR. ZUBAIR IS THE CO-PRINCIPAL INVESTIGATOR OF THIS PROJECT. HE WILL BE RESPONSIBLE FOR MANAGING AND COORDINATING THE PORTION OF THE RESEARCH TO BE CARRIED OUT AT MAYO CLINIC FLORIDA. HE IS EXPERT IN GENERATING AND CHARACTERIZING HEMATOPOIETIC STEM CELLS (HSC) FOR BONE MARROW TRANSPLANT AND REGENERATIVE MEDICINE APPLICATION. HE HAS OVER 18 YEARS€„¢ EXPERIENCE IN CELL THERAPY AND GROWING MSC UNDER DIFFERENT CONDITIONS. HE SUCCESSFULLY GREW AND CHARACTERIZED HSC AT ISS UNDER MICROGRAVITY CONDITION. DR. ZUBAIR WILL ENSURE THAT KNOWLEDGE GENERATED AS THE PROJECT PROCEEDS IS SHARED. HE WILL BE RESPONSIBLE TO ENSURE SUCCESS OF HIS RESEARCH TEAM EFFORT. DR. ZUBAIR WILL CONSULT AND COLLABORATE WITH DR. STODIECK€„¢S LAB, BIOSERVE, COLORADO UNIVERSITY TO CONDUCT THE EXPERIMENTS PROPOSED IN THIS GRANT PROPOSAL. HE AND HIS TEAM WILL BE RESPONSIBLE FOR GENERATING, ANALYZING HSC TO BE USED IN THIS PROJECT, CONDUCTING ALL PREFLIGHT VALIDATION STUDIES AND WILL PERFORM FURTHER EXPERIMENTS POSTFLIGHT AND HELP IN THE DATA ANALYSIS. HIS TEAM, WITH ASSISTANCE OF DR. STODIECK€„¢S TEAM WILL PERFORM ALL EXPERIMENTS AS OUTLINED UNDER EACH SPECIFIC AIMS AND SUB-AIMS. ZUBAIR€„¢S TEAM WILL BE RESPONSIBLE FOR GENERATING, COLLECTING AND ANALYZING ALL BIOLOGICAL DATA. WITH INPUT FROM RELEVANT COLLABORATORS, HIS TEAM WILL PREPARE MANUSCRIPTS FOR PUBLICATION IN PEER REVIEWED JOURNALS. 1562422 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541990 Parent award performance state: CO Parent award description: PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS, LYMPHOMAS, MULTIPLE MYELOMA), FATAL BLOOD DISORDERS, AND SEVERE IMMUNE DISEASES. View parent award on USAspending | 80JSC019D0026USAspending | $240,000 | Oct 2, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | IN HER ROLE AS A MEMBER OF THE FRAMINGHAM HEART STUDY EXECUTIVE COMMITTEE, DR. ERTEKIN-TANER WILL ATTEND TWICE MONTHLY MEETINGS, REVIEW PROPOSALS ASSIGNED TO HER, PROVIDE INPUT REGARDING OTHER PROPOSALS AND POLICY MATTERS DISCUSSED AT THE EXECUTIVE COMMITTEE LEVEL.
III. OBJECTIVES
1. ATTEND TWICE MONTHLY MEETINGS AND AD HOC MEETINGS AS APPLICABLE.
2. REVIEW ASSIGNED PROPOSALS.
3. PROVIDE CONSULTATION ON OTHER PROPOSALS AND POLICY MATTERS. 4500004700 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MA Parent award description: FRAMINGHAM HEART STUDY TASK ORDER 1 - BASE PERIOD View parent award on USAspending | 75N92019D00031USAspending | $58,852 | Jul 3, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | IN HER ROLE AS A MEMBER OF THE FRAMINGHAM HEART STUDY EXECUTIVE COMMITTEE, DR. ERTEKIN-TANER WILL ATTEND
TWICE MONTHLY MEETINGS, REVIEW PROPOSALS ASSIGNED TO HER, PROVIDE INPUT REGARDING OTHER PROPOSALS AND POLICY
MATTERS DISCUSSED AT THE EXECUTIVE COMMITTEE LEVEL.
III. OBJECTIVES
1. ATTEND TWICE MONTHLY MEETINGS AND AD HOC MEETINGS AS APPLICABLE.
2. REVIEW ASSIGNED PROPOSALS.
3. PROVIDE CONSULTATION ON OTHER PROPOSALS AND POLICY MATTERS. 4500004573 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MA Parent award description: FRAMINGHAM HEART STUDY TASK ORDER 1 - BASE PERIOD View parent award on USAspending | 75N92019D00031USAspending | $60,204 | Jan 20, 2023 | — – — |
| Subcontractor | National Aeronautics and Space Administration | ZUBAIR€„¢S TEAM, MAYO CLINIC FLORIDA: ABBA C ZUBAIR MD., PHD IS THE MEDICAL DIRECTOR OF
TRANSFUSION MEDICINE AND STEM THERAPY LABORATORY AND PROFESSOR OF LABORATORY MEDICINE AND
PATHOLOGY. DR. ZUBAIR IS THE CO-PRINCIPAL INVESTIGATOR OF THIS PROJECT. HE WILL BE RESPONSIBLE FOR
MANAGING AND COORDINATING THE PORTION OF THE RESEARCH TO BE CARRIED OUT AT MAYO CLINIC FLORIDA. HE
IS EXPERT IN GENERATING AND CHARACTERIZING HEMATOPOIETIC STEM CELLS (HSC) FOR BONE MARROW
TRANSPLANT AND REGENERATIVE MEDICINE APPLICATION. HE HAS OVER 18 YEARS€„¢ EXPERIENCE IN CELL THERAPY
AND GROWING MSC UNDER DIFFERENT CONDITIONS. HE SUCCESSFULLY GREW AND CHARACTERIZED HSC AT ISS
UNDER MICROGRAVITY CONDITION. DR. ZUBAIR WILL ENSURE THAT KNOWLEDGE GENERATED AS THE PROJECT
PROCEEDS IS SHARED. HE WILL BE RESPONSIBLE TO ENSURE SUCCESS OF HIS RESEARCH TEAM EFFORT. DR. ZUBAIR
WILL CONSULT AND COLLABORATE WITH DR. STODIECK€„¢S LAB, BIOSERVE, COLORADO UNIVERSITY TO CONDUCT THE
EXPERIMENTS PROPOSED IN THIS GRANT PROPOSAL. HE AND HIS TEAM WILL BE RESPONSIBLE FOR GENERATING,
ANALYZING HSC TO BE USED IN THIS PROJECT, CONDUCTING ALL PREFLIGHT VALIDATION STUDIES AND WILL PERFORM
FURTHER EXPERIMENTS POSTFLIGHT AND HELP IN THE DATA ANALYSIS. HIS TEAM, WITH ASSISTANCE OF DR.
STODIECK€„¢S TEAM WILL PERFORM ALL EXPERIMENTS AS OUTLINED UNDER EACH SPECIFIC AIMS AND SUB-AIMS.
ZUBAIR€„¢S TEAM WILL BE RESPONSIBLE FOR GENERATING, COLLECTING AND ANALYZING ALL BIOLOGICAL DATA. WITH
INPUT FROM RELEVANT COLLABORATORS, HIS TEAM WILL PREPARE MANUSCRIPTS FOR PUBLICATION IN PEER REVIEWED
JOURNALS. 1562422 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541990 Parent award performance state: CO Parent award description: PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS, LYMPHOMAS, MULTIPLE MYELOMA), FATAL BLOOD DISORDERS, AND SEVERE IMMUNE DISEASES. View parent award on USAspending | 80JSC019D0026USAspending | $210,000 | Oct 31, 2022 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.